Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
Chymase has several functions, such as angiotensin II formation, which can promote diabetic kidney disease (DKD). In this study, we evaluated the effect of the chymase inhibitor TY-51469 on DKD in diabetic db/db mice. Diabetic mice were administered TY-51469 (10 mg/kg/day) or placebo for 4 weeks. No...
Main Authors: | Kentaro Terai, Denan Jin, Kenji Watase, Akihisa Imagawa, Shinji Takai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7495 |
Similar Items
-
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2020-10-01) -
Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2018-02-01) -
Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet
by: Yuta Miyaoka, et al.
Published: (2017-07-01) -
Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors
by: Gunnar Pejler
Published: (2020-06-01) -
Mast Cell Chymase and Kidney Disease
by: Shamila Vibhushan, et al.
Published: (2021-12-01)